CL vs COLL
Colgate-Palmolive Company (CL) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CL currently screens at market cap $70.88B and trailing P/E 34.3. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CL and COLL stock pages for the full models.
Not investment advice.